Skip to main content
Premium Trial:

Request an Annual Quote

Lynx Stockholders Approve Solexa-Lynx Merger

NEW YORK, March 1 (GenomeWeb News) - Lynx Therapeutics announced today that its shareholders approved six proposed items - including the company's proposed merger with Solexa - at its annual shareholders meeting held today.


The closing of the merger is now subject to acceptance by Solexa shareholders of Lynx's offer to acquire the entire issued share capital of Solexa.


Lynx said that it expects the merger to close later this month.


The companies announced their plans to merge in August.

The Scan

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.

Study Highlights Pitfall of Large Gene Panels in Clinical Genomic Analysis

An analysis in Genetics in Medicine finds that as gene panels get larger, there is an increased chance of uncovering benign candidate variants.

Single-Cell Atlas of Drosophila Embryogenesis

A new paper in Science presents a single-cell atlas of fruit fly embryonic development over time.

Phage Cocktail Holds Promise for IBD

Researchers uncovered a combination phage therapy that targets Klebsiella pneumonia strains among individuals experiencing inflammatory bowel disease flare ups, as they report in Cell.